M.M. Leblond

655 total citations
16 papers, 475 citations indexed

About

M.M. Leblond is a scholar working on Immunology, Cancer Research and Surgery. According to data from OpenAlex, M.M. Leblond has authored 16 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in M.M. Leblond's work include Immune cells in cancer (6 papers), Immune Cell Function and Interaction (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). M.M. Leblond is often cited by papers focused on Immune cells in cancer (6 papers), Immune Cell Function and Interaction (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). M.M. Leblond collaborates with scholars based in Switzerland, France and Italy. M.M. Leblond's co-authors include Grégory Verdeil, Samuel Valable, Myriam Bernaudin, Eric T. MacKenzie, Aurélien Corroyer‐Dulmont, Edwige Petit, Dominique Velin, Hana Zdimerova, Clément Anfray and Elodie A. Pérès and has published in prestigious journals such as The EMBO Journal, Nature Immunology and Cancer Research.

In The Last Decade

M.M. Leblond

15 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.M. Leblond Switzerland	10	233	167	147	127	103	16	475
Götz Lehnerdt Germany	11	234 1.0×	257 1.5×	82 0.6×	74 0.6×	46 0.4×	13	498
Sabrina Carpentier France	9	372 1.6×	225 1.3×	128 0.9×	39 0.3×	69 0.7×	11	573
Filippos Kontos United States	8	153 0.7×	252 1.5×	92 0.6×	87 0.7×	75 0.7×	15	429
Lukas Marcelis Belgium	12	98 0.4×	186 1.1×	102 0.7×	53 0.4×	34 0.3×	26	487
Lillian Sun United States	7	298 1.3×	378 2.3×	120 0.8×	45 0.4×	63 0.6×	9	508
Pingping Hu China	10	309 1.3×	268 1.6×	107 0.7×	31 0.2×	55 0.5×	19	515
Haoran Zha China	11	297 1.3×	203 1.2×	130 0.9×	22 0.2×	65 0.6×	20	484
Antonina Avanzi United States	6	368 1.6×	352 2.1×	109 0.7×	45 0.4×	42 0.4×	7	591
Alessandra Vaccaro Italy	11	153 0.7×	175 1.0×	86 0.6×	16 0.1×	64 0.6×	22	675
Annegé Vledder Netherlands	4	307 1.3×	404 2.4×	139 0.9×	51 0.4×	126 1.2×	9	626

Countries citing papers authored by M.M. Leblond

Since Specialization

Citations

This map shows the geographic impact of M.M. Leblond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.M. Leblond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.M. Leblond more than expected).

Fields of papers citing papers by M.M. Leblond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.M. Leblond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.M. Leblond. The network helps show where M.M. Leblond may publish in the future.

Co-authorship network of co-authors of M.M. Leblond

This figure shows the co-authorship network connecting the top 25 collaborators of M.M. Leblond. A scholar is included among the top collaborators of M.M. Leblond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.M. Leblond. M.M. Leblond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Glanville, Nicholas, Claudia Prevosto, Sonia Domingos‐Pereira, et al.. (2025). Abstract 1673: Advancing bladder cancer treatment with live attenuated salmonella ZH9: from monotherapy to combination strategies. Cancer Research. 85(8_Supplement_1). 1673–1673. 2 indexed citations

Leblond, M.M., et al.. (2024). Flow cytometry detection and quantification of circulating leukocyte subpopulations in mice after brain irradiation. Methods in cell biology. 135–152. 1 indexed citations

Zdimerova, Hana, et al.. (2024). Development of Traceable Mouse Models of Advanced and Metastatic Bladder Cancer. Cancers. 16(12). 2245–2245.

Hadadi, Noushin, Sara Simões Costa, Laura Ciarloni, et al.. (2024). Immuno-Transcriptomic Profiling of Blood and Tumor Tissue Identifies Gene Signatures Associated with Immunotherapy Response in Metastatic Bladder Cancer. Cancers. 16(2). 433–433. 1 indexed citations

Tillé, Laure, Mélanie Charmoy, Patrick Reichenbach, et al.. (2023). Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion. Nature Immunology. 24(10). 1645–1653. 24 indexed citations

Trabanelli, Sara, Giuseppe Ercolano, Tania Wyss, et al.. (2022). c‐Maf enforces cytokine production and promotes memory‐like responses in mouse and human type 2 innate lymphoid cells. The EMBO Journal. 41(12). e109300–e109300. 21 indexed citations

Oster, P, Erika Riva, Caroline Truntzer, et al.. (2021). Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies. Gut. 71(3). 457–466. 129 indexed citations

Leblond, M.M., et al.. (2021). Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy. Cancers. 13(18). 4712–4712. 44 indexed citations

Leblond, M.M., Laure Tillé, Sina Nassiri, et al.. (2020). CD40 Agonist Restores the Antitumor Efficacy of Anti-PD1 Therapy in Muscle-Invasive Bladder Cancer in an IFN I/II-Mediated Manner. Cancer Immunology Research. 8(9). 1180–1192. 29 indexed citations

10.

Leblond, M.M., et al.. (2020). Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical Study. Cancers. 12(12). 3585–3585. 3 indexed citations

11.

Valable, Samuel, M.M. Leblond, Clément Anfray, et al.. (2020). Impact of Hypoxia on Carbon Ion Therapy in Glioblastoma Cells: Modulation by LET and Hypoxia-Dependent Genes. Cancers. 12(8). 2019–2019. 26 indexed citations

12.

Leblond, M.M., et al.. (2019). Maf deficiency in T cells dysregulates Treg - TH17 balance leading to spontaneous colitis. Scientific Reports. 9(1). 6135–6135. 14 indexed citations

13.

Leblond, M.M., et al.. (2019). Impact of Angiopoietin-2 on glioblastoma response to combined chemo-radiotherapy. Annals of Oncology. 30. v801–v802. 1 indexed citations

14.

Leblond, M.M., Elodie A. Pérès, Clément Anfray, et al.. (2017). M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma. Oncotarget. 8(42). 72597–72612. 83 indexed citations

15.

Chakhoyan, Ararat, Aurélien Corroyer‐Dulmont, M.M. Leblond, et al.. (2016). Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models. Journal of Cerebral Blood Flow & Metabolism. 37(6). 2270–2282. 12 indexed citations

16.

Leblond, M.M., et al.. (2015). Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models. OncoImmunology. 5(1). e1056442–e1056442. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact